Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TSA lifting liquid, gel ban in ‘09

This article was originally published in The Tan Sheet

Executive Summary

The Transportation Security Administration intends to remove airline carry-on restrictions on liquids, aerosols and gels - including toothpaste and other personal care products - by fall 2009, the agency says Oct. 24. In 2010, TSA expects Advanced Technology X-Ray systems, which can differentiate between threat and non-threat liquids, to be widespread enough to negate the need for restrictions. Passengers currently may carry on liquids in 3 oz. bottles inside a clear plastic bag, though TSA began allowing up to 4 oz. of nonprescription liquid medication and certain amounts of infant formula in August 2006 (1"The Tan Sheet" Aug. 21, 2006, In Brief)

You may also be interested in...



OTCs in carry-ons

Four ounces of non-prescription liquid medications, up to five ounces of low blood sugar treatments and small amounts of breast milk and baby formula will be allowed in carry-on bags according to the new TSA security procedures issued Aug. 13. Breast milk and baby formula will only be allowed if a passenger is traveling with a baby or toddler. All items including medication will be x-rayed unless a passenger asks for visual inspection...

QUOTED. 9 April 2020. Frans van Houten.

Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.

COVID-19 Lock-Down: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

Topics

UsernamePublicRestriction

Register

PS102293

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel